New Imaging Guidelines for Monoclonal Plasma Cell Disorders

Jens Hillengass, MD, Chief of Myeloma at Roswell Park Comprehensive Cancer Center, reviews new imaging guidelines for multiple myeloma, as well as other monoclonal plasma cell disorders, that were published in The Lancet Oncology. These guidelines are a result of a study, conducted by an international working group and led by Dr. Hillengass, to improve diagnosis and treatment plans.

Created by

Roswell Park Comprehensive Cancer Center

Related Presenters

Jens Hillengass, MD, PhD

Jens Hillengass, MD, PhD

Chief of Myeloma, Professor of Oncology

While in Medical School I focused my research on the investigation of morphological and functional imaging of hematological diseases, especially monoclonal plasma cell disorders.